In summary, our study found that CCL7 levels are elevated in the secretory phase endometrium of PCOS patients, suggesting that it plays a key role in exacerbating chronic inflammation, insulin resistance, ovarian dysfunction, and endometrial dysfunction. This evidence concerns the gene CCL7 and ovarian dysfunction.